Cosmetics Australia - Directory of
Cosmetic Beauty, Health and Wellbeing

Photo Gallery

Xeomin Injections – Is this the new botox?

Xeomin Injections – Is this the new botox?

Published: 28/10/2012 by Mario M Anders

» Cosmetic Surgery
» Non-Surgical Cosmetic Procedures

 First came Botox, then Dysport,

 

and now Xeomin.

Launched in the UK in 2008, the American Food and Drug Administration  recently approved the new botulinum toxin product to treat severe frown lines between the eyebrows.

As is the case in the UK, Xeomin was previously approved for use in adults with cervical dystonia and also blepharospasm.

 

Cervical dystonia is a condition which is distinguished by the abnormal neck pain and movements, and a blepharospasm is the abnormal and involuntary blinking or spasm of the eyelids.

 

Xeomin is manufactured by the company Merz Pharmaceuticals, and has been already used by more than 84,000 people worldwide. It is now approved for use in 20 countries. The approval was for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.

 

Like other Botulinum drugs in this category, Xeomin works by paralyzing wrinkles. It blocks the signals between the nerves to the muscles and as a result, the targeted muscles cannot contract.

 

Xeomin, Botox and Dysport

 

All three - Botox, Dysport and Xeomin have a lot in common, and they also have some important differences which need to be taken into account. It is widely accepted that bacterial proteins which are present in other products do play a significant role as promoters of an immune reaction, thus resulting in a loss of effect and a reduction in activity duration.

 

Xeomin does not need to be refrigerated, as it is devoid of certain proteins, which is not the same for the others in this toxin-sphere.

Will it revolutionize the way wrinkles are frozen?

“Time will only tell,” says Manhattan dermatologist, Patricia Wexler, who has used Botox for over 20-years. “As of now, Botox lasts up to three or four months. If Xeomin does last longer, say up to six-months and meets all safety standards, then it will be a home run.” This may also lessen a patient’s chances of developing antibodies to Xeomin as occurs with other botulinum toxin.

 

It takes about seven to ten days for the full effects of Xeomin injections to be really work fully, and once this occurs then the results will last from between three and six months. Most patients find that the injections cause little discomfort. Many compare the feeling to a little insect bite! As the treatment is very quick, the needles used are tiny and only minute amounts of liquid are being injected into the skin; few patients experience any significant pain.

 

A few patients do, however, prefer to have an aesthetic cream applied half an hour or so prior to treatment to help numb the skin.

 

 

The side effects associated with the use of Xeomin are no different to other botulinum toxins, with bruising or bleeding at the site of the injection, headache and more rarely drooping of the eyelid, double vision and brow droop.